Eli Lilly And Company (LLY): Today's Featured Health Care Winner - TheStreet

Eli Lilly and Company

(

LLY

) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 1.4%. By the end of trading, Eli Lilly and Company rose 31 cents (0.7%) to $42.07 on light volume. Throughout the day, 3.8 million shares of Eli Lilly and Company exchanged hands as compared to its average daily volume of 6.3 million shares. The stock ranged in a price between $41.82-$42.14 after having opened the day at $41.92 as compared to the previous trading day's close of $41.76. Other companies within the Health Care sector that increased today were:

Alexza Pharmaceuticals

(

ALXA

), up 44.9%,

Response Genetics

(

RGDX

), up 29.1%,

Medgenics

(

MDGN

), up 20.6%, and

Geron Corporation

(

GERN

), up 15.4%.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. Eli Lilly and Company has a market cap of $48.78 billion and is part of the

drugs

industry. The company has a P/E ratio of 10.9, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 1.2% year to date as of the close of trading on Thursday. Currently there are three analysts that rate Eli Lilly and Company a buy, two analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Eli Lilly and Company as a

buy

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, solid stock price performance, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front,

Theratechnologies

(

THER

), down 59.7%,

Rexahn Pharmaceuticals

(

RNN

), down 18.4%,

Idera Pharmaceuticals

(

IDRA

), down 16.7%, and

K-V Pharmaceutical Company

(

KV.A

), down 15.5%, were all losers within the health care sector with

Mindray Medical International

(

MR

) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

null